Development of a Multivariable Model to Predict the Need for Bone Marrow Sampling in Persons With Monoclonal Gammopathy of Undetermined Significance : A Cohort Study Nested in a Clinical Trial.

Autor: Eythorsson E; Landspítali-The National University Hospital of Iceland and Faculty of Medicine, University of Iceland, Reykjavík, Iceland (E.E., S.R., P.T.O., B.A.A., R.P., O.S.I., S.Y.K.)., Rognvaldsson S; Landspítali-The National University Hospital of Iceland and Faculty of Medicine, University of Iceland, Reykjavík, Iceland (E.E., S.R., P.T.O., B.A.A., R.P., O.S.I., S.Y.K.)., Thorsteinsdottir S; Faculty of Medicine, University of Iceland, Reykjavík, Iceland, and Department of Hematology, Rigshospitalet, Copenhagen, Denmark (S.T.)., Einarsson Long T; Faculty of Medicine, University of Iceland, Reykjavík, Iceland, and Skåne University Hospital, Lund, Sweden (T.E.L.)., Reed ER; Faculty of Medicine, University of Iceland, Reykjavík, Iceland (E.R.R., G.A.S., A.R.T., G.K.G., A.O., J.S., T.J.L.)., Sigurdardottir GA; Faculty of Medicine, University of Iceland, Reykjavík, Iceland (E.R.R., G.A.S., A.R.T., G.K.G., A.O., J.S., T.J.L.)., Vidarsson B; Landspítali-The National University Hospital of Iceland, Reykjavík, Iceland (B.V., M.S., I.O., I.T., S.V.S., F.S., H.S.)., Onundarson PT; Landspítali-The National University Hospital of Iceland and Faculty of Medicine, University of Iceland, Reykjavík, Iceland (E.E., S.R., P.T.O., B.A.A., R.P., O.S.I., S.Y.K.)., Agnarsson BA; Landspítali-The National University Hospital of Iceland and Faculty of Medicine, University of Iceland, Reykjavík, Iceland (E.E., S.R., P.T.O., B.A.A., R.P., O.S.I., S.Y.K.)., Sigurdardottir M; Landspítali-The National University Hospital of Iceland, Reykjavík, Iceland (B.V., M.S., I.O., I.T., S.V.S., F.S., H.S.)., Olafsson I; Landspítali-The National University Hospital of Iceland, Reykjavík, Iceland (B.V., M.S., I.O., I.T., S.V.S., F.S., H.S.)., Thorsteinsdottir I; Landspítali-The National University Hospital of Iceland, Reykjavík, Iceland (B.V., M.S., I.O., I.T., S.V.S., F.S., H.S.)., Sveinsdottir SV; Landspítali-The National University Hospital of Iceland, Reykjavík, Iceland (B.V., M.S., I.O., I.T., S.V.S., F.S., H.S.)., Sigurdsson F; Landspítali-The National University Hospital of Iceland, Reykjavík, Iceland (B.V., M.S., I.O., I.T., S.V.S., F.S., H.S.)., Thordardottir AR; Faculty of Medicine, University of Iceland, Reykjavík, Iceland (E.R.R., G.A.S., A.R.T., G.K.G., A.O., J.S., T.J.L.)., Palsson R; Landspítali-The National University Hospital of Iceland and Faculty of Medicine, University of Iceland, Reykjavík, Iceland (E.E., S.R., P.T.O., B.A.A., R.P., O.S.I., S.Y.K.)., Indridason OS; Landspítali-The National University Hospital of Iceland and Faculty of Medicine, University of Iceland, Reykjavík, Iceland (E.E., S.R., P.T.O., B.A.A., R.P., O.S.I., S.Y.K.)., Jonsson A; Akureyri Hospital, Akureyri, Iceland (A.J.)., Gislason GK; Faculty of Medicine, University of Iceland, Reykjavík, Iceland (E.R.R., G.A.S., A.R.T., G.K.G., A.O., J.S., T.J.L.)., Olafsson A; Faculty of Medicine, University of Iceland, Reykjavík, Iceland (E.R.R., G.A.S., A.R.T., G.K.G., A.O., J.S., T.J.L.)., Sigurdsson J; Faculty of Medicine, University of Iceland, Reykjavík, Iceland (E.R.R., G.A.S., A.R.T., G.K.G., A.O., J.S., T.J.L.)., Steingrimsdottir H; Landspítali-The National University Hospital of Iceland, Reykjavík, Iceland (B.V., M.S., I.O., I.T., S.V.S., F.S., H.S.)., Hultcrantz M; Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, New York (M.H.)., Durie BGM; Cedars-Sinai Samuel Oschin Cancer Center, Los Angeles, California (B.G.M.D.)., Harding S; The Binding Site, Birmingham, West Midlands, United Kingdom (S.H.)., Landgren O; Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida (O.L.)., Aspelund T; Center for Public Health Sciences, University of Iceland, Reykjavík, Iceland (T.A.)., Love TJ; Faculty of Medicine, University of Iceland, Reykjavík, Iceland (E.R.R., G.A.S., A.R.T., G.K.G., A.O., J.S., T.J.L.)., Kristinsson SY; Landspítali-The National University Hospital of Iceland and Faculty of Medicine, University of Iceland, Reykjavík, Iceland (E.E., S.R., P.T.O., B.A.A., R.P., O.S.I., S.Y.K.).

Publikováno v: Annals of internal medicine [Ann Intern Med] 2024 Apr; Vol. 177 (4), pp. 449-457. Date of Electronic Publication: 2024 Apr 02.

Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study.

Autor: Long TE; University of Iceland, Reykjavik, Iceland.; Skane University Hospital, Lund, Sweden.; Landspitali-The National University Hospital of Iceland, Reykjavik, Iceland., Indridason OS; Landspitali-The National University Hospital of Iceland, Reykjavik, Iceland., Palsson R; University of Iceland, Reykjavik, Iceland.; Landspitali-The National University Hospital of Iceland, Reykjavik, Iceland., Rognvaldsson S; University of Iceland, Reykjavik, Iceland.; Landspitali-The National University Hospital of Iceland, Reykjavik, Iceland., Love TJ; University of Iceland, Reykjavik, Iceland.; Landspitali-The National University Hospital of Iceland, Reykjavik, Iceland., Thorsteinsdottir S; University of Iceland, Reykjavik, Iceland.; Department of Hematology, Rigshospitalet, Copenhagen, Denmark., Sverrisdottir IS; University of Iceland, Reykjavik, Iceland.; Sahlgrenska University Hospital, Gothenburg, Sweden., Vidarsson B; Landspitali-The National University Hospital of Iceland, Reykjavik, Iceland., Onundarson PT; University of Iceland, Reykjavik, Iceland.; Landspitali-The National University Hospital of Iceland, Reykjavik, Iceland., Agnarsson BA; University of Iceland, Reykjavik, Iceland.; Landspitali-The National University Hospital of Iceland, Reykjavik, Iceland., Sigurdardottir M; Landspitali-The National University Hospital of Iceland, Reykjavik, Iceland., Thorsteinsdottir I; Landspitali-The National University Hospital of Iceland, Reykjavik, Iceland., Olafsson I; Landspitali-The National University Hospital of Iceland, Reykjavik, Iceland., Thordardottir AR; University of Iceland, Reykjavik, Iceland., Eythorsson E; Landspitali-The National University Hospital of Iceland, Reykjavik, Iceland., Jonsson A; University of Iceland, Reykjavik, Iceland.; Landspitali-The National University Hospital of Iceland, Reykjavik, Iceland., Gislason G; University of Iceland, Reykjavik, Iceland., Olafsson A; University of Iceland, Reykjavik, Iceland., Steingrimsdottir H; Landspitali-The National University Hospital of Iceland, Reykjavik, Iceland., Hultcrantz M; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Durie BGM; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Outpatient Cancer Center, Los Angeles, CA, USA., Harding S; Binding Site Group Ltd, Birmingham, UK., Landgren O; Myeloma Program, Department of Medicine, University of Miami, Sylvester Comprehensive Cancer Center, Miami, USA., Kristinsson SY; University of Iceland, Reykjavik, Iceland. sigyngvi@hi.is.; Landspitali-The National University Hospital of Iceland, Reykjavik, Iceland. sigyngvi@hi.is.

Publikováno v: Blood cancer journal [Blood Cancer J] 2022 Sep 14; Vol. 12 (9), pp. 133. Date of Electronic Publication: 2022 Sep 14.

Monoclonal gammopathy of undetermined significance and COVID-19: a population-based cohort study.

Autor: Rognvaldsson S; Faculty of Medicine, University of Iceland, Reykjavik, Iceland.; Landspítali-The National University Hospital of Iceland, Reykjavik, Iceland., Eythorsson E; Landspítali-The National University Hospital of Iceland, Reykjavik, Iceland., Thorsteinsdottir S; Faculty of Medicine, University of Iceland, Reykjavik, Iceland.; Rigshospitalet, Copenhagen, Denmark., Vidarsson B; Landspítali-The National University Hospital of Iceland, Reykjavik, Iceland., Onundarson PT; Faculty of Medicine, University of Iceland, Reykjavik, Iceland.; Landspítali-The National University Hospital of Iceland, Reykjavik, Iceland., Agnarsson BA; Faculty of Medicine, University of Iceland, Reykjavik, Iceland.; Landspítali-The National University Hospital of Iceland, Reykjavik, Iceland., Sigurdardottir M; Landspítali-The National University Hospital of Iceland, Reykjavik, Iceland., Thorsteinsdóttir I; Landspítali-The National University Hospital of Iceland, Reykjavik, Iceland., Olafsson I; Faculty of Medicine, University of Iceland, Reykjavik, Iceland.; Landspítali-The National University Hospital of Iceland, Reykjavik, Iceland., Runolfsdottir HL; Landspítali-The National University Hospital of Iceland, Reykjavik, Iceland., Helgason D; Landspítali-The National University Hospital of Iceland, Reykjavik, Iceland., Emilsdottir AR; Landspítali-The National University Hospital of Iceland, Reykjavik, Iceland., Agustsson AS; Faculty of Medicine, University of Iceland, Reykjavik, Iceland.; Landspítali-The National University Hospital of Iceland, Reykjavik, Iceland., Bjornsson AH; Faculty of Medicine, University of Iceland, Reykjavik, Iceland.; Landspítali-The National University Hospital of Iceland, Reykjavik, Iceland., Kristjansdottir G; Landspítali-The National University Hospital of Iceland, Reykjavik, Iceland., Thordardottir AR; Faculty of Medicine, University of Iceland, Reykjavik, Iceland., Indridason OS; Faculty of Medicine, University of Iceland, Reykjavik, Iceland.; Landspítali-The National University Hospital of Iceland, Reykjavik, Iceland., Jonsson A; Akureyri Hospital, Akureyri, Iceland., Gislason GK; Faculty of Medicine, University of Iceland, Reykjavik, Iceland., Olafsson A; Faculty of Medicine, University of Iceland, Reykjavik, Iceland., Steingrimsdottir H; Landspítali-The National University Hospital of Iceland, Reykjavik, Iceland., Kampanis P; The Binding Site ltd, Birmingham, UK., Hultcrantz M; Memorial Sloan-Kettering Cancer Center, New York City, NY, USA., Durie BGM; Cedar-Sinai Samual Oschin Cancer Center, Los Angeles, CA, USA., Harding S; The Binding Site ltd, Birmingham, UK., Landgren O; Sylvester Cancer Center, University of Miami, Miami, FL, USA., Palsson R; Faculty of Medicine, University of Iceland, Reykjavik, Iceland.; Landspítali-The National University Hospital of Iceland, Reykjavik, Iceland., Love TJ; Faculty of Medicine, University of Iceland, Reykjavik, Iceland.; Landspítali-The National University Hospital of Iceland, Reykjavik, Iceland., Kristinsson SY; Faculty of Medicine, University of Iceland, Reykjavik, Iceland. sigyngvi@hi.is.; Landspítali-The National University Hospital of Iceland, Reykjavik, Iceland. sigyngvi@hi.is.

Publikováno v: Blood cancer journal [Blood Cancer J] 2021 Dec 01; Vol. 11 (12), pp. 191. Date of Electronic Publication: 2021 Dec 01.

Improved progression free survival with bortezomib consolidation after high dose melphalan: results of a randomised phase III trial

Autor: Mellquist, U. H., Gimsing, P, Hjertner, O, Lenhoff, S, Laane, E, Remes, K, Steingrimsdottir, H, Abildgaard , Niels, Ahlberg, L, Blimark, C, Carlsson, K, Dahl, I M, Forsberg, K, Andersen, N F, Gedde-Dahl, T, Gregersen, H, Gruber, A, Guldbrandsen, N, Haukas, E, Juliusson, G, Lindas, R, Linder, N, Nahi, N, Silvennoinen, R, Swedin, A, Toffner-Clausen, N, Turesson, I, Waage, A, Westin, J

Publikováno v: Mellquist, U H, Gimsing, P, Hjertner, O, Lenhoff, S, Laane, E, Remes, K, Steingrimsdottir, H, Abildgaard, N, Ahlberg, L, Blimark, C, Carlsson, K, Dahl, I M, Forsberg, K, Andersen, N F, Gedde-Dahl, T, Gregersen, H, Gruber, A, Guldbrandsen, N, Haukas, E, Juliusson, G, Lindas, R, Linder, N, Nahi, N, Silvennoinen, R, Swedin, A, Toffner-Clausen, N, Turesson, I, Waage, A & Westin, J 2011, ' Improved progression free survival with bortezomib consolidation after high dose melphalan: results of a randomised phase III trial ', 13th International Meoloma Workshop, Paris, France, 03/06/2011-06/06/2011 .

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3062::de8b0b1cc6f8f8eb371c8d965492c702
https://portal.findresearcher.sdu.dk/da/publications/8bddd10d-a8e8-4fcd-a507-c5999240d28a

Løn under forældreorlov.

Autor: ANDERSEN, SIMON KYLLEBÆK¹, SØGAARD, JAKOB EGHOLT¹

Publikováno v: Samfundsøkonomen. jul2024, Issue 3, p41-50. 10p.